A detailed history of Paradigm Financial Partners, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Paradigm Financial Partners, LLC holds 879 shares of UTHR stock, worth $320,246. This represents 0.04% of its overall portfolio holdings.

Number of Shares
879
Holding current value
$320,246
% of portfolio
0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$311.04 - $363.55 $273,404 - $319,560
879 New
879 $314,000
Q4 2021

Feb 10, 2022

BUY
$184.32 - $216.08 $402,554 - $471,918
2,184 New
2,184 $471,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Paradigm Financial Partners, LLC Portfolio

Follow Paradigm Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Financial Partners, LLC with notifications on news.